Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy

References

• Baetke SC, Lammers T, Kiessling F. (2015). Applications of nanoparticles for diagnosis and therapy of cancer. Br J Radiol 88:20150207.
   PubMed Web of Science ®Google Scholar
• Baloglu E, Kingston DGI. (1999). The taxane diterpenoids. J Nat Prod 62:1448–72.
   PubMed Web of Science ®Google Scholar
• Bianchini G, Balko JM, Mayer IA, et al. (2016). Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13:674.
   PubMed Web of Science ®Google Scholar
• Chu C, Xu P, Zhao H, et al. (2016). Effect of surface ligand density on cytotoxicity and pharmacokinetic profile of docetaxel loaded liposomes. Asian J Pharm Sci 11:655–61.
   Web of Science ®Google Scholar
• de Weger VA, Beijnen JH, Schellens JH. (2014). Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel: a review. Anticancer Drugs 25:488–94.
   PubMed Web of Science ®Google Scholar
• Fischer I, Petkaumilroy K, Dorland YL, et al. (2013). Self-assembled fluorescent organic nanoparticles for live-cell imaging. Chem Eur J 19:16646–50.
   PubMed Web of Science ®Google Scholar
• Han X, Chen J, Jiang M, et al. (2016). Paclitaxel–paclitaxel prodrug nanoassembly as a versatile nanoplatform for combinational cancer therapy. ACS Appl Mater Interfaces 8:33506–13.
   PubMed Web of Science ®Google Scholar
• Liu K, Jiang X, Hunziker P. (2016). Carbohydrate-based amphiphilic nano delivery systems for cancer therapy. Nanoscale 8:16091–156.
   PubMed Web of Science ®Google Scholar
• Luo C, Sun J, Liu D, et al. (2016). Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy. Nano Lett 16:5401–8.
   PubMed Web of Science ®Google Scholar
• Luo C, Sun J, Sun B, et al. (2014). Prodrug-based nanoparticulate drug delivery strategies for cancer therapy. Trends Pharmacol Sci 35:556–66.
   PubMed Web of Science ®Google Scholar
• Luo C, Wang Y, Chen Q, et al. (2012). Advances of paclitaxel formulations based on nanosystem delivery technology. Mini Rev Med Chem 12:434.
   PubMed Web of Science ®Google Scholar
• Matsubara T, Otani R, Yamashita M, et al. (2017). Selective intracellular delivery of ganglioside GM3-binding peptide through caveolae/raft-mediated endocytosis. Biomacromolecules 18:355.
   PubMed Web of Science ®Google Scholar
• Mishra P, Nayak B, Dey RK. (2016). PEGylation in anti-cancer therapy: an overview. Asian J Pharm Sci 11:337–48.
   Web of Science ®Google Scholar
• Petersen GH, Alzghari SK, Chee W, et al. (2016). Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin. J Control Release 232:255–64.
   PubMed Web of Science ®Google Scholar
• Powell MJD. (1977). Restart procedures for the conjugate gradient method. Math Program 12:241–54.
   Web of Science ®Google Scholar
• Ren G, Jiang M, Xue P, et al. (2016a). A unique highly hydrophobic anticancer prodrug self-assembled nanomedicine for cancer therapy. Nanomed Nanotechnol 12:2273–82.
   PubMed Web of Science ®Google Scholar
• Ren G, Liu D, Guo W, et al. (2016b). Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation. Drug Deliv 23:1272–81.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. (2016). Cancer statistics, 2016. CA Cancer J Clin 66:7–30.
   PubMed Web of Science ®Google Scholar
• Sorolla A, Ho D, Wang E, et al. (2016). Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide. Nanoscale 8:9343–53.
   PubMed Web of Science ®Google Scholar
• Sun B, Luo C, Li L, et al. (2016a). Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxe. Colloid Surface B 143:47–55.
   PubMed Web of Science ®Google Scholar
• Sun M, Wu C, Fu Q, et al. (2016b). Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions. Int J Pharm 503:238–46.
   PubMed Web of Science ®Google Scholar
• Tan L, Peng J, Zhao Q, et al. (2017a). A Novel MPEG-PDLLA-PLL copolymer for docetaxel delivery in breast cancer therapy. Theranostics 7:2652–72.
   PubMed Web of Science ®Google Scholar
• Tan L, Ma B, Zhao Q, et al. (2017b). Toxicity evaluation and anti-tumor study of docetaxel oaded mPEG-polyester micelles for breast cancer therapy. J Biomed Nanotechnol 13:393–408.
   PubMed Web of Science ®Google Scholar
• Wais U, Jackson AW, He T, et al. (2016). Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles. Nanoscale 8:1746–69.
   PubMed Web of Science ®Google Scholar
• Wang T, Feng L, Yang S, et al. (2017). Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency. Drug Deliv 24:800–10.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu D, Zheng Q, et al. (2014). Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines. Nano Lett 14:5577–83.
   PubMed Web of Science ®Google Scholar
• Wu Z, Zheng J. (2016). Nanoparticles for taxanes delivery in cancer treatment. J Nanosci Nanotechnol 16:6634–47.
   Web of Science ®Google Scholar
• Xu Y, Wang C, Ding Y, et al. (2016). Nanoparticles with optimal ratiometric co-delivery of docetaxel with gambogic acid for treatment of multidrug-resistant breast cancer. J Biomed Nanotechnol 12:1774–81.
   PubMed Web of Science ®Google Scholar
• Xue P, Liu D, Wang J, et al. (2016). Redox-sensitive citronellol -cabazitaxel conjugate: maintained in vitro cytotoxicity and self-assembled as multifunctional nanomedicine. Bioconjugate Chem 27:1360–72.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Cai T, Xi X, et al. (2016). Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer. Drug Deliv 23:3350–7.
   PubMed Web of Science ®Google Scholar
• Zhang S, Sun M, Zhao Y, et al. (2017). Molecular mechanism of polymer-assisting supersaturation of poorly water-soluble loratadine based on experimental observations and molecular dynamic simulations. Drug Deliv Transl Res 7:738–49.
   PubMed Web of Science ®Google Scholar